颈椎内侧支阻滞是否具有治疗作用?一项前瞻性队列研究
本研究采用前瞻性队列设计,纳入179例既往颈椎内侧支阻滞后报告50%缓解的患者,共830个阻滞节段,在门诊环境下操作,基线及每2周随访12周,评估疼痛评分、颈部功能障碍指数和患者整体印象变化等。结果显示2周时62.2%患者疼痛评分下降≥30%,12周时降至22.7%,所有疼痛、情绪和躯体功能指标在2周和12周与基线比较均有统计学显著差异。结论提示部分患者可能获得超出局麻药预期持续时间的临床获益。
要点
- 颈椎内侧支阻滞后2周62.2%患者疼痛评分下降≥30%,12周降至22.7%。
- 疼痛、情绪和躯体功能指标在2周和12周与基线比较均有统计学显著差异。
- 探索性分析未发现年龄、阿片类使用、疼痛病因、既往手术或治疗节段与疼痛评分变化相关。
核心结论
- 部分接受颈椎内侧支阻滞的患者可能出现超出局麻药预期持续时间的临床获益。
研究设计与样本
- 前瞻性队列研究,纳入179例既往颈椎内侧支阻滞后报告50%缓解的患者,共830个阻滞节段,在门诊环境下操作。
主要发现
- 2周时62.2%患者报告疼痛评分下降≥30%,12周时降至22.7%。
- 所有疼痛、情绪和躯体功能指标在2周和12周与基线比较均有统计学显著差异。
- 探索性分析未发现年龄、阿片类使用、疼痛病因、既往手术、治疗节段(上 vs 下颈椎)与第0–2周及第2–12周数字评分变化相关。
关键数值与推荐
- 既往颈椎内侧支阻滞后报告50%缓解为纳入条件。
- 结局指标包括数字疼痛评分、颈部功能障碍指数、患者整体印象变化,每2周随访12周;疼痛灾难化量表、广泛性焦虑障碍7项和患者健康问卷9项每4周完成。
临床怎么用
- 颈椎内侧支阻滞除诊断用途外,部分患者可能获得超出局麻药预期持续时间的疼痛缓解,临床可关注这一潜在治疗效应。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cervical medial branch blocks (CMBB) are used for the diagnosis of facet joint-related pain. There have been several reports suggesting that they can provide a benefit that significantly outlasts the expected duration of diagnostic blocks. We undertook this study to determine the frequency and extent of this effect in clinical practice. METHODS: 179 patients undergoing 830 individual block levels and who had previously reported 50% relief following a CMBB were recruited using a prospective cohort design and blocks were performed in an outpatient setting. Outcomes monitored at baseline and every 2 weeks for 12 weeks included numerical pain scores, Neck Disability Index and Patient Global Impression of Change. In addition, the Pain Catastrophizing Scale, Generalized Anxiety Disorder 7 and Patient Health Questionnaire 9 were completed every 4 weeks. RESULTS: Statistically significant differences were found for all measures of pain, emotional and physical functioning, when comparing 2 and 12-week measurements to baseline. At 2 weeks, 62.2% of patients reported a 30% or greater decrease in pain scores, which decreased to 22.7% at 12 weeks. Exploratory analysis found no association between age, opioid use, pain etiology, previous surgery, levels treated (upper vs lower cervical) and change in Numerical Rating Score between weeks 0 and 2, as well as between weeks 2 and 12. CONCLUSION: Our findings suggest that a proportion of patients undergoing CMBB may experience clinical benefits that exceed the expected duration of local anesthetics. Further research is required to determine the potential clinical applications of these findings. TRIAL REGISTRATION NUMBER: NCT04852393.
引用
- Finlayson RJ, Etheridge JB, Godard R, et al. Do cervical medial branch blocks have a therapeutic role? a prospective cohort study. Reg Anesth Pain Med. 2026. PMID: 40441772. doi:10.1136/rapm-2025-106457
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。